Literature DB >> 8897060

Expression of vascular endothelial growth factor in human myocardial infarction.

K Shinohara1, T Shinohara, N Mochizuki, Y Mochizuki, H Sawa, T Kohya, M Fujita, Y Fujioka, A Kitabatake, K Nagashima.   

Abstract

To define mechanisms that may influence collateral circulation and angiogenesis, we investigated vascular endothelial growth factor (VEGF) mRNA expression in human hearts. In non-ischemic human hearts, VEGF mRNA was not detected in vessels, but was found in cardiomyocytes. In hearts with myocardial infarction, the intensity of the VEGF signal was much higher in smooth muscle cells of arterioles adjacent to necrosis and in infiltrating macrophages than in myocytes around the site of the necrosis. This study suggests that levels of VEGF expression are high in smooth muscle cells and macrophages around infarcted areas after myocardial infarction and that VEGF may play a role in promoting collateral circulation and angiogenesis in human ischemic hearts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897060     DOI: 10.1007/bf01745169

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

Review 1.  The collateral circulation of the heart.

Authors:  W Schaper; G Görge; B Winkler; J Schaper
Journal:  Prog Cardiovasc Dis       Date:  1988 Jul-Aug       Impact factor: 8.194

2.  Pathways and functional significance of the coronary collateral circulation.

Authors:  D C Levin
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

3.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

4.  Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

Authors:  D R Senger; D T Connolly; L Van de Water; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

5.  Exerimental coronary artery occlusion. III. The determinants of collateral blood flow in acute coronary occlusion.

Authors:  W Schaper
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

6.  Molecular biology of the coronary vascular and myocardial responses to ischemia.

Authors:  H S Sharma; M Wünsch; T Brand; P D Verdouw; W Schaper
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

7.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

Authors:  K A Houck; D W Leung; A M Rowland; J Winer; N Ferrara
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

8.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

9.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.

Authors:  F Goto; K Goto; K Weindel; J Folkman
Journal:  Lab Invest       Date:  1993-11       Impact factor: 5.662

10.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

2.  Dynamics of vascular growth factors after coronary angioplasty.

Authors:  Iu I Buziashvili; S T Matskeplishvili; D Kh Kamardinov; A V Staferov; M A El'darov; K G Skryabin; M P Kirpichnikov; L A Bokeriia; R V Petrov
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

Review 3.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

4.  Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.

Authors:  Chujun Yuan; Lin Yan; Pallavi Solanki; Stephen F Vatner; Dorothy E Vatner; Margaret A Schwarz
Journal:  J Mol Cell Cardiol       Date:  2014-11-29       Impact factor: 5.000

Review 5.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 6.  A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.

Authors:  Xinli Zhang; Chen Chen
Journal:  Endocrine       Date:  2012-02-10       Impact factor: 3.633

7.  Imaging of VEGF receptor in a rat myocardial infarction model using PET.

Authors:  Martin Rodriguez-Porcel; Weibo Cai; Olivier Gheysens; Jürgen K Willmann; Kai Chen; Hui Wang; Ian Y Chen; Lina He; Joseph C Wu; Zi-bo Li; Khalid A Mohamedali; Sehoon Kim; Michael G Rosenblum; Xiaoyuan Chen; Sanjiv Sam Gambhir
Journal:  J Nucl Med       Date:  2008-04       Impact factor: 10.057

8.  Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.

Authors:  Barbara ErŽen; Mira Šilar; Mišo Šabovič
Journal:  BMC Cardiovasc Disord       Date:  2014-11-22       Impact factor: 2.298

9.  Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus.

Authors:  Derya Güzel; Ali Doğan Dursun; Hakan Fıçıcılar; Demet Tekin; Ayhan Tanyeli; Fırat Akat; Ferda Topal Çelikkan; Bizden Sabuncuoğlu; Metin Baştuğ
Journal:  Anatol J Cardiol       Date:  2015-04-09       Impact factor: 1.596

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.